Effect of bromocriptine on affect and libido in hyperprolactinemia.

Area of Science:

• Endocrinology
• Psychiatry
• Sexual Health

Background:

• Primary hyperprolactinemia is a condition characterized by elevated prolactin levels.
• Hyperprolactinemia can affect mood and sexual function.
• Understanding the impact of hyperprolactinemia on quality of life is crucial.

Purpose of the Study:

• To investigate the effects of hyperprolactinemia on mood and sexual function in women.
• To evaluate the efficacy of bromocriptine in treating symptoms associated with hyperprolactinemia.
• To compare outcomes between hyperprolactinemic patients and healthy controls.

Main Methods:

• A randomized, double-blind, placebo-controlled crossover study was conducted.
• Six women with primary hyperprolactinemia were matched with six normal controls.
• Subjects were treated with bromocriptine (2.5 mg twice daily) or placebo for 5 weeks each.

Main Results:

• Hyperprolactinemic patients exhibited higher Hamilton scores (indicating mild depression) during placebo but not during bromocriptine treatment compared to controls.
• Libido levels were similar between groups during both placebo and bromocriptine treatment.
• Mean orgasmic frequency was lower in patients than controls, with no significant change during bromocriptine treatment.

Conclusions:

• Hyperprolactinemia in women is associated with mild depression.
• A decrease in orgasmic frequency may be linked to hyperprolactinemia.
• Bromocriptine may alleviate depressive symptoms but does not appear to restore orgasmic frequency in this cohort.